Business Context and Reporting Period
This Form 8-K Current Report was filed by Pathfinder Bancorp, Inc. (PBHC) on October 7, 2022, covering events occurring on September 28, 2022. The filing addresses the departure of a senior officer and the execution of a separation agreement.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The only financial data disclosed relates to the specific compensation package for the departing executive:
- Severance Payment: $60,000 (less applicable taxes and withholdings), payable within 15 days of the agreement's effective date.
- Health Benefits: Company-paid health and dental coverage through November 30, 2022, if the executive elects COBRA coverage.
Material Changes
The primary material change reported is the resignation of Thomas W. Schneider, the former Director of Capital Markets and Corporate Strategy, effective September 7, 2022. On September 28, 2022, the Company entered into a Separation Agreement and Release with Mr. Schneider. This agreement includes a general release of claims, subject to a 7-day revocation period, and becomes effective on the 8th calendar day after signing.
Outlook, Risks, and Unusual Items
The filing contains no forward-looking guidance, outlook, or management commentary regarding the Company's future financial performance. The agreement includes standard non-disparagement, non-disclosure, and non-solicitation provisions. Mr. Schneider has agreed to cooperate with reasonable requests for information regarding his prior position and with any third-party litigation or investigations, with the Company agreeing to reimburse reasonable expenses associated with such cooperation.
Investor Verification Checklist
- Verify the effective date of the separation agreement to confirm the timeline for the $60,000 payment.
- Review the full text of the Separation Agreement (Exhibit 10.1) for specific details on non-solicitation and non-compete restrictions.
- Confirm if the departure of the Director of Capital Markets impacts the Company's strategic capital planning or market access.
- Check subsequent filings for the appointment of a replacement for the Director of Capital Markets and Corporate Strategy role.